http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-102007026701-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_eab56e4fe8837840887f41af83e328ee |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F5-027 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F19-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F5-02 |
| filingDate | 2007-06-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_800223eba8da3e34bb71c9e99bb894be http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3c4cbaf28be7c0b98610650ba4c1763c |
| publicationDate | 2008-12-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | DE-102007026701-A1 |
| titleOfInvention | New chemical compounds, their preparation and their use |
| abstract | ThenPatent application relates to chemical compounds having a basic structure,nselected from salicylic acid, acetylsalicylic acid,nAPHS (o-acetoxyphenylhept-2-inylfulfide), salen ligands, diflunisal,nSalsalate, benorylate, phenylalkanylcarboxylic acids (in particularnFenoprofen, ibuprofen, ketoprofen, flurbiprofen, naproxen, tolmetin,nSulindac, indomethacin, diclofenac, carprofen, etodolac, ketorolac),nOxicamine inhibitors (especially tenoxicam, prioxicam, meloxicam),nAnthranil acids: (especially mefenamic acid,nMeclofenamic acid) sulfonamides (especially celecoxibnand valdecoxib), methylsulfones (especially rofecoxib, etoricoxibnDuP697 (CAS 88149-94-4), NS398 (CAS 123653-11-2), flosulide (CGP28238),nNimesulide, diarylheterocycles (especially sodium parcoxib), propanamidesn(especially parecoxib), butazones (especially phenylbutazone,nOxyphenylbutazone), paracetamol, phenacetin, phenazone, dipyrone, amidopyrinenand esters and acid amides of said compounds,nMethotrexate, Br-WR99219, trimethoprim, tipranavir, indinavir, ritonavir,nJH-174 and NMB-006, thyronine, thyroxine and triiodothyronine, butylscopolaminium bromide,nClonidine, duloxetine, fenoterol, losartan, oxazepam, lorazepam, salbutamol,nThiotropium bromide, atorvastatin, simvastatin, olanzapine, amlodipine,nClopidogrel, sertraline, resveratrol, 1-phenylpropan-2-amine and N-methyl-1-phenylpropan-2-amine,nEphedrine and the pharmaceutically acceptable salts,nHydrates, solvates and metal complexes of said compounds,n... |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9290529-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013060307-A1 |
| priorityDate | 2007-06-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 468.